Interventions for selective prevention of emotional problems in adolescents: a systematic review

The prevalence of anxiety and depression problems in adolescents is increasing and is currently an important public health problem. The aim of this study was to analyze, through a systematic review, the existing selective prevention treatments focused on the treatment of anxiety and depression symptoms in adolescents, as well as the extent of their effect and their methodological characteristics. Three international databases were used in this study: PsycINFO, Pubmed and Medline. After applying the eligibility criteria, five studies were included for review. The results revealed that the studies focused on the prevention of anxiety and depression, with great variability in terms of the methodology used and showing moderate levels of improvement only in medium to long term follow-ups. In conclusion, there is a need to expand the amount of research focusing on selective prevention for emotional problems in children and adolescents from a transdiagnostic approach that includes follow-up assessments.Intervenciones para la prevención selectiva de problemas emocionales en adolescentes: una revisión sistemática. La prevalencia de problemas de ansiedad y depresión en adolescentes está aumentando y actualmente es un importante problema de salud pública. El objetivo de este estudio fue analizar, mediante una revisión sistemática, los tratamientos de prevención selectiva existentes centrados en el tratamiento de los síntomas de ansiedad y depresión en adolescentes, así como el alcance de su efecto y sus características metodológicas. Se utilizaron tres bases de datos internacionales para este estudio: PsycINFO, Pubmed y Medline. Después de aplicar los criterios de elegibilidad, se incluyeron cinco estudios para su revisión. Los resultados revelaron que los estudios se centraron en la prevención de la ansiedad y la depresión, con una gran variabilidad en cuanto a la metodología utilizada y mostrando niveles moderados de mejora solo en seguimientos a medio-largo plazo. En conclusión, existe la necesidad de ampliar la cantidad de investigaciones centradas en la prevención selectiva de problemas emocionales en niños y adolescentes desde un enfoque transdiagnóstico que incluya evaluaciones de seguimiento

Upconversion cooling of Er-doped low-phonon fluorescent solids

We report on a novel mechanism for laser cooling of fluorescent solids based on infrared-to-visible upconversion often found in rare-earth-doped low-phonon materials. This type of optical cooling presents some advantages with regards to conventional anti-Stokes cooling. Among them, it allows to obtain cooling in a broader range of frequencies around the barycenter of the infrared emitting band.Comment: 4 pages, 1 figur

As xoias de Regodreigón.

66 (1-2) Jan.-Jun. 1956, p. 90-96

Fingerprint Image-Quality Estimation and its Application to Multialgorithm Verification

Signal-quality awareness has been found to increase recognition rates and to support decisions in multisensor environments significantly. Nevertheless, automatic quality assessment is still an open issue. Here, we study the orientation tensor of fingerprint images to quantify signal impairments, such as noise, lack of structure, blur, with the help of symmetry descriptors. A strongly reduced reference is especially favorable in biometrics, but less information is not sufficient for the approach. This is also supported by numerous experiments involving a simpler quality estimator, a trained method (NFIQ), as well as the human perception of fingerprint quality on several public databases. Furthermore, quality measurements are extensively reused to adapt fusion parameters in a monomodal multialgorithm fingerprint recognition environment. In this study, several trained and nontrained score-level fusion schemes are investigated. A Bayes-based strategy for incorporating experts past performances and current quality conditions, a novel cascaded scheme for computational efficiency, besides simple fusion rules, is presented. The quantitative results favor quality awareness under all aspects, boosting recognition rates and fusing differently skilled experts efficiently as well as effectively (by training).Comment: Published at IEEE Transactions on Information Forensics and Securit

Chitosan feasibility to retain retinal stem cell phenotype and slow proliferation for retinal transplantation

Retinal stem cells (RSCs) are promising in cell replacement strategies for retinal diseases. RSCs can migrate, differentiate, and integrate into retina. However, RSCs transplantation needs an adequate support; chitosan membrane (ChM) could be one, which can carry RSCs with high feasibility to support their integration into retina. RSCs were isolated, evaluated for phenotype, and subsequently grown on sterilized ChM and polystyrene surface for 8 hours, 1, 4, and 11 days for analysing cell adhesion, proliferation, viability, and phenotype. Isolated RSCs expressed GFAP, PKC, isolectin, recoverin, RPE65, PAX-6, cytokeratin 8/18, and nestin proteins. They adhered (28 ± 16%, 8 hours) and proliferated (40 ± 20 cells/field, day 1 and 244 ± 100 cells/field, day 4) significantly low on ChM. However, they maintained similar viability (>95%) and phenotype (cytokeratin 8/18, PAX6, and nestin proteins expression, day 11) on both surfaces (ChM and polystyrene). RSCs did not express alpha-SMA protein on both surfaces. RSCs express proteins belonging to epithelial, glial, and neural cells, confirming that they need further stimulus to reach a final destination of differentiation that could be provided in in vivo condition. ChM does not alternate RSCs behaviour and therefore can be used as a cell carrier so that slow proliferating RSCs can migrate and integrate into retina

Trypsin/α-amylase inhibitors and thionins: possible defence proteins from barley

This chapter reviews recent work on the trypsin/α-amylase inhibitor and thionin protein families. The genomic distribution of protein genes in barley and related species, gene expression and in vitro activities are considered. Some of the evidence of a possible defence role against stored products pests for inhibitors and thionins is briefly discusse

Anti-Stokes laser cooling in bulk Erbium-doped materials

We report the first observation of anti-Stokes laser-induced cooling in the Er^{3+}:KPb_{2}Cl_{5} crystal and in the Er^{3+}:CNBZn (CdF_{2}-CdCl_{2}-NaF-BaF_{2}-BaCl_{2}-ZnF_{2}) glass. The internal cooling efficiencies have been calculated by using photothermal deflection spectroscopy. Thermal scans acquired with an infrared thermal camera proved the bulk cooling capability of the studied samples. Implications of these results are discussed.Comment: 4 pages, 4 figures. The figures enclosed with this submission are low quality ones. Versions of this paper with high quality figures are available upon reques

Lower Success Rate of Debridement and Implant Retention in Late Acute versus Early Acute Periprosthetic Joint Infection Caused by Staphylococcus spp. Results from a Matched Cohort Study

Background Surgical debridement, antibiotics and implant retention (DAIR) is currently recommended by international guidelines for both early acute (postsurgical) and late acute (hematogenous) periprosthetic joint infections (PJIs). However, due to a different pathogenesis of infection, a different treatment strategy may be needed. Questions/purposes (1) Compared with early acute PJIs, are late acute PJIs associated with a higher risk of DAIR failure? (2) When stratified by microorganism, is the higher risk of failure in late acute PJI associated with Staphylocococcus aureus infection? (3) When analyzing patients with S. aureus infection, what factors are independently associated with DAIR failure? Methods In this multicenter observational study, early acute and late acute PJIs treated with DAIR were retrospectively evaluated and matched according to treating center, year of diagnosis, and infection-causing microorganism. If multiple matches were available, the early acute PJI diagnosed closest to the late acute PJI was selected. A total of 132 pairs were included. Treatment success was defined as a retained implant during follow-up without the need for antibiotic suppressive therapy. Results Late acute PJIs had a lower treatment success (46% [60 of 132]) compared with early acute PJIs (76% [100 of 132]), OR 3.9 [95% CI 2.3 to 6.6]; p <0.001), but the lower treatment success of late acute PJIs was only observed when caused by Staphylococcus spp (S. aureus: 34% versus 75%; p <0.001; coagulase-negative staphylococci: 46% versus 88%; p = 0.013, respectively). On multivariable analysis, late acute PJI was the only independent factor associated with an unsuccessful DAIR when caused by S. aureus (OR 4.52 [95% CI 1.79 to 11.41]; p <0.001). Conclusions Although DAIR seems to be a successful therapeutic strategy in the management of early acute PJI, its use in late acute PJI should be reconsidered when caused by Staphylococcus spp. Our results advocate the importance of isolating the causative microorganism before surgery

The Multiscenario Multienvironment BioSecure Multimodal Database (BMDB)

A new multimodal biometric database designed and acquired within the framework of the European BioSecure Network of Excellence is presented. It is comprised of more than 600 individuals acquired simultaneously in three scenarios: 1) over the Internet, 2) in an office environment with desktop PC, and 3) in indoor/outdoor environments with mobile portable hardware. The three scenarios include a common part of audio/video data. Also, signature and fingerprint data have been acquired both with desktop PC and mobile portable hardware. Additionally, hand and iris data were acquired in the second scenario using desktop PC. Acquisition has been conducted by 11 European institutions. Additional features of the BioSecure Multimodal Database (BMDB) are: two acquisition sessions, several sensors in certain modalities, balanced gender and age distributions, multimodal realistic scenarios with simple and quick tasks per modality, cross-European diversity, availability of demographic data, and compatibility with other multimodal databases. The novel acquisition conditions of the BMDB allow us to perform new challenging research and evaluation of either monomodal or multimodal biometric systems, as in the recent BioSecure Multimodal Evaluation campaign. A description of this campaign including baseline results of individual modalities from the new database is also given. The database is expected to be available for research purposes through the BioSecure Association during 2008Comment: Published at IEEE Transactions on Pattern Analysis and Machine Intelligence journa

Safety and efficacy of ribociclib plus letrozole in patients with HR+, HER2– advanced breast cancer: Results from the Spanish sub-population of the phase 3b CompLEEment-1 trial

Background: Breast cancer is the most common malignancy and the second leading cause of cancer-related mortality in Spanish women. Ribociclib in combination with endocrine therapy (ET) has shown superiority in prolonging survival in patients with hormone receptor-positive (HR+), human epidermal growth factor receptor 2-negative (HER2-) advanced breast cancer (ABC) vs. ET alone.Methods: CompLEEment-1 is a single-arm, open-label phase 3b trial evaluating ribociclib plus letrozole in a broad population of patients with HR+, HER2- ABC. The primary endpoints were safety and tolerability. Here we report data for Spanish patients enrolled in CompLEEment-1.Results: A total of 526 patients were evaluated (median follow-up: 26.97 months). Baseline characteristics showed a diverse population with a median age of 54 years. At study entry, 56.5% of patients had visceral metastases and 8.7% had received prior chemotherapy for advanced disease. Rates of all-grade and Grade >= 3 adverse events (AEs) were 99.0% and 76.2%, respectively; 21.3% of patients experienced a serious AE, and 15.8% of AEs led to treatment discontinuation. AEs of special interest of neutropenia, increased alanine aminotransferase, increased aspartate aminotransferase and QTcF prolongation occurred in 77.8%, 14.8%, 11.4% and 4.0% of patients, respectively. Patients aged >70 years experienced increased rates of all-grade and Grade >= 3 neutropenia and anemia. Efficacy results were consistent with the global study.Conclusions: Results from Spanish patients enrolled in CompLEEment-1 are consistent with global data showing efficacy and a manageable safety profile for ribociclib plus letrozole treatment in patients with HR+, HER2-ABC, including populations of interest (NCT02941926).Trial registration: ClinicalTrials.gov NCT0294192